You are here

KCTV: New drug gives multiple sclerosis patients a new option

Imagine having a condition where your body attacks itself. You could lose the ability to do everyday tasks. Walk in your home. Brush your teeth. Feed yourself. Now there is a new hope for patients who have primary progressive multiple sclerosis. Dr. Christine Boutwell, director of the Multiple Sclerosis Center at Saint Luke's Marion Bloch Neuroscience Institute, says a new drug is shown to slow down the progression of the disease, which could change the quality of life for her patients.

See the full report here.